期刊文献+

携带人衰变加速因子基因转基因小鼠的建立 被引量:2

Establishment of transgenic mice carrying human decay accelerating factor
原文传递
导出
摘要 目的 通过建立转人衰变加速因子 (DAF)基因小鼠 ,为研究异种器官移植的超急性排斥反应提供有效的研究手段。方法 采用受精卵显微注射技术 ,将人DAF基因导入小白鼠受精卵的原核中。Dot blot及Southern blot杂交确定阳性转基因小鼠。以Northern杂交法检测人DAF基因的表达情况。结果 基因注射后共生出小鼠 2 4只 ,4只为转基因小鼠 ,人DAF基因在其中 1只小鼠体内得到表达。结论 所导入的人DAF基因在小鼠的基因组中实现整合及表达。 Objective To develop transgenic mice carrying human decay accelerating factor(DAF)to provide an effective method for the study on xenogeneic hyperacute organ rejection. Methods A DNA fragment was isolated from plasmid, pSFFV DAF, consisting of SFFV 5'LTR as the promoter, hDAF cDNA and SV40 splice/poly A. Then the fragment was microinjected into male pronucleus of fertilized eggs of the Kunming mice. The genomic DNA was isolated from the the tail of the newborn mice with 4 week old. Dot blot and Southern blot hybridization methods were applied to identify the founder transgenic mice. Total RNA was isolated from kidney of transgenic mice, then Northern blot hybridization was used to detect the expression of hDAF gene in the transgenic mice. Results After microinjection of the gene, a total of 500 live fertilized eggs were obtained and were implanted into the oviducts of 24 pseudopregnant female mice. Human DAF gene was expression in one of the 4 transgenic mice. Conclusion The introduced hDAF gene has been integrated and expressed in those mice genome.
出处 《中华器官移植杂志》 CAS CSCD 2000年第6期322-324,共3页 Chinese Journal of Organ Transplantation
基金 国家自然科学基金资助项目(39570671)
关键词 移植 异种 衰变加速因子 小鼠 转基因 Transplantation,heterologous Decay accelerating factor Mouse transgenic
  • 相关文献

参考文献3

  • 1J.萨姆布鲁克 E.F弗里奇.分子克隆实验指南(第2版)[M].北京:科学出版社,1996.465-467.
  • 2金冬雁(译),分子克隆实验指南(第2版),1996年
  • 3Johnston P S,Transplantation,1992年,54卷,573页

共引文献15

同被引文献17

  • 1张志宏,马腾骧,王广有,张月,李胜芝,李光三,刘思金,劳为德.异种移植血管内皮细胞组织特异性表达人CD59转基因小鼠的建立[J].中华实验外科杂志,2005,22(12):1578-1580. 被引量:2
  • 2J·萨姆布鲁克 黄培堂 译.分子克隆实验指南(第3版)[M].北京:科学出版社,2002.492-499.
  • 3Cowan PJ, Shinkel TA, Fisicaro N, et al. Targeting gene expression to endothelium in transgenic animals: a comparison of the human ICAM-2, PECAM-1 and endoglin promoters. Xenotranslpantation, 2003, 10: 223-231.
  • 4He Z, She R, Sumitran-Holgersson S, et al. The in vitro activity and specificity of human endothelial cell-specific promoters in porcine cells. Xenotransplantation, 2001, 8: 202-212.
  • 5Cowan PJ, Shinkel TA, Aminian A, et al. High-level co-expression of complement regulators on vascular endothelium in transgenic mice: CD55 and CD 59 provide greater protection from human complement-mediated injury than DAF alone. Xenotransplantation, 1998, 5: 184-190.
  • 6Peter J, Cowan, Christine A, et al. High-level endothelial expression of human DAF prolongs heart function in ex vivo model of xenograft rejection. Transplantation, 1998, 65 : 826-829.
  • 7马腾骧.现代泌尿外科学[M].天津:天津科学技术出版社,2000.697-710.
  • 8Mollnes TE,Fiane AE.Xenotransplantation:How to overcome the complement obstacle[J].Mol Immunol,1999,36(2):269
  • 9Kobayashi T,Taniguchi S,Neethling FA,et al.Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy[J].Transplantation,1997,64(8):1255
  • 10Cozzi E,Masroor S,Soin B,et al.Progress in xenotranslpantation[J].Clin Nephrol,2000,53(1):13

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部